-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 LDrR9YqG0oAfoI7rA2chw5XF/JZdoJxsZYC+0QLYYjR+oZ+mXmqG6Qg5g+Xq3ZXC
 PDcOd/5O4kiXVBe61/h4Uw==

<SEC-DOCUMENT>0001275287-06-001022.txt : 20060222
<SEC-HEADER>0001275287-06-001022.hdr.sgml : 20060222
<ACCEPTANCE-DATETIME>20060222150138
ACCESSION NUMBER:		0001275287-06-001022
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20060222
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20060222
DATE AS OF CHANGE:		20060222

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			KEWAUNEE SCIENTIFIC CORP /DE/
		CENTRAL INDEX KEY:			0000055529
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY APPARATUS & FURNITURE [3821]
		IRS NUMBER:				380715562
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0430

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-05286
		FILM NUMBER:		06635954

	BUSINESS ADDRESS:	
		STREET 1:		2700 W FRONT ST
		CITY:			STATESVILLE
		STATE:			NC
		ZIP:			28677
		BUSINESS PHONE:		7048737202

	MAIL ADDRESS:	
		STREET 1:		P O BOX 1842
		CITY:			STATESVILLE
		STATE:			NC
		ZIP:			28687-1842

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	KEWAUNEE SCIENTIFIC EQUIPMENT CORP /DE/
		DATE OF NAME CHANGE:	19861216

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	KEWAUNEE MANUFACTURING CO
		DATE OF NAME CHANGE:	19680108
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ks4894.txt
<DESCRIPTION>FORM 8-K
<TEXT>
================================================================================

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
     PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

       Date of Report (Date of earliest event reported) February 22, 2006

                         KEWAUNEE SCIENTIFIC CORPORATION
             ------------------------------------------------------
             (Exact name of registrant as specified in its charter)

            Delaware                     0-5286                38-0715562
  ----------------------------        ------------        -------------------
  (State or other jurisdiction        (Commission          (I.R.S. Employer
        of incorporation)             File Number)        Identification No.)

             2700 West Front Street
           Statesville, North Carolina                           28677
    ----------------------------------------                   ----------
    (Address of principal executive offices)                   (Zip Code)

         Registrant's telephone number, including area code 704-873-7202

                                       N/A
         --------------------------------------------------------------
         (Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:

[ ]  Written communications pursuant to Rule 425 under the Securities
     Act (17 CFR 230.425)

[ ]  Soliciting material pursuant to Rule 14a-12 under the Exchange
     Act (17 CFR 240.14a-12)

[ ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the
     Exchange Act (17 CFR 240.14d-2(b))

[ ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the
     Exchange Act (17 CFR 240.13a-4(c))

================================================================================

<PAGE>

ITEM  2.02    RESULTS OF OPERATIONS AND FINANCIAL CONDITIONS

On February 22, 2006, Kewaunee Scientific Corporation issued a press release
announcing its financial results for the third quarter ended January 31, 2006. A
copy of the Press Release is furnished as Exhibit 99.1 to this Current Report on
Form 8-K.

ITEM  9.01    FINANCIAL STATEMENTS AND EXHIBITS

  (d)  EXHIBITS:

  EXHIBIT NO.
  -----------
      99.1       Press Release of Kewaunee Scientific Corporation dated
                 February 22, 2006

In accordance with General Instruction B.2 of Form 8-K, the information in this
Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed "filed"
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended
(the "Exchange Act"), or otherwise subject to the liabilities of that section,
and shall not be incorporated by reference into any registration statement or
other document filed under the Securities Act of 1933, as amended, or the
Exchange Act, except as shall be expressly set forth by specific reference in
such filing.

<PAGE>

                                    SIGNATURE

       Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                                 Kewaunee Scientific Corporation
                                                 (Registrant)


Date: February 22, 2006                          /s/ D. MICHAEL PARKER
                                                 -------------------------------
                                                 Senior Vice President, Finance
                                                 Chief Financial Officer
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ks4894ex991.txt
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
                                                                    Exhibit 99.1

   KEWAUNEE SCIENTIFIC ANNOUNCES THIRD QUARTER RESULTS AND QUARTERLY DIVIDEND

    STATESVILLE, N.C., Feb. 22 /PRNewswire-FirstCall/ -- Kewaunee Scientific
Corporation (Nasdaq: KEQU) today reported results for its third quarter ended
January 31, 2006.

    Sales for the quarter were $17,724,000, an increase of 13% over sales of
$15,623,000 in the same period last year. A net loss of $555,000, or $0.22 per
diluted share, was reported for the quarter. This compares to a net loss of
$742,000, or $0.30 per diluted share, in the same period last year. The order
backlog at January 31, 2006 was $35.5 million. This compares to a backlog of
$35.2 million at the beginning of the quarter and $41.7 million at January 31,
2005.

    A number of factors adversely affected earnings for the quarter. An
unexpected cost of $230,000 was incurred when the Company's installation
subcontractor on a large project was unable to complete the installation.
Additionally, energy costs increased 66%, or $205,000, over the same period last
year. The third quarter is traditionally the Company's weakest quarter for sales
and earnings, and these costs made the quarter even more difficult.

    As expected, costs and manufacturing disruptions associated with the
completion of three significant cost improvement projects in the Company's
Statesville plants adversely impacted results for the quarter. A new $1.8
million finishing system was installed in the Wood Plant. This more efficient
system required an entire new layout of the finishing and assembly areas of the
facility. This system is now performing well, our Associates have been trained,
and the Company should benefit from reduced costs beginning in our fourth
quarter. Other projects completed during the quarter included a new automated
folding machine in the Metal Plant at a cost of $900,000 and new continuous
casting machine in the Resin Plant at a cost of $256,000, both of which are
installed and performing well.

    The Company's financial condition remains strong. Cash on hand at the end of
the quarter was $1.3 million and working capital was $11.5 million, while total
debt was $7.1 million. Book value per share was $10.41 at January 31, 2006.

    "The unexpected costs associated with replacing a subcontractor and a
further significant jump in energy costs made the third quarter especially
difficult," said William A. Shumaker, President and Chief Executive Officer of
Kewaunee. "However, we believe our fourth quarter will have increased sales and
be profitable. We continue to make progress in reducing our costs for the
long-term. The capital projects in our plants completed during the quarter will
allow us to reduce our operating costs, and we continue to make good progress in
reducing our raw material costs by finding alternative vendors and more
competitive pricing. The domestic marketplace for our laboratory products
continues to be reasonably healthy, although pricing remains extremely
competitive. Our international subsidiaries in Asia serving the
rapidly-expanding Asian laboratory research market continue to grow and
contribute nicely to our sales and profits."

    Sales for the nine months ended January 31, 2006 were $60,351,000, an
increase of 11% over sales of $54,276,000 in the comparable period last year.
Net earnings for the nine months were $447,000, or $0.18 per diluted share,
including a net gain of $540,000, or $0.22 per diluted share, from the sale of
our former Lockhart, Texas property in the first quarter. A net loss of
$441,000, or $0.18 per diluted share, was reported in the comparable period last
year.

<PAGE>

    The Company also announced today that its Board of Directors approved a cash
dividend of seven cents per outstanding share to stockholders of record at the
close of business on March 6, 2006, payable on March 20, 2006.

    Kewaunee Scientific Corporation is a recognized leader in the design,
manufacture, and installation of scientific and technical furniture. The
Company's corporate headquarters and manufacturing facilities are located in
Statesville, North Carolina. The Company also has subsidiaries in Singapore and
Bangalore, India that serve the Asian markets. Kewaunee Scientific's website is
located at http://www.kewaunee.com.

    Certain statements in this release constitute "forward-looking" statements
within the meaning of the Private Securities Litigation Reform Act of 1995. Such
forward-looking statements involve known and unknown risks, uncertainties and
other factors that could significantly impact results or achievements expressed
or implied by such forward-looking statements. These factors include, but are
not limited to, economic, competitive, governmental, and technological factors
affecting the Company's operations, markets, products, services, and prices.

                      Consolidated Statements of Operations
                                   (unaudited)
                      (in thousands, except per share data)

<TABLE>
<CAPTION>
                                            3 Months Ended              9 Months Ended
                                              January 31                  January 31
                                       ------------------------    -------------------------
                                          2006          2005          2006           2005
                                       ----------    ----------    ----------     ----------
<S>                                    <C>           <C>           <C>            <C>
Net sales                              $   17,724    $   15,623    $   60,351     $   54,276

Cost of products sold                      15,278        13,586        51,034         45,310
Gross profit                                2,446         2,307         9,317          8,966

Operating expenses                          3,079         3,030         8,952          9,336

Operating earnings (loss)                    (633)         (993)          365           (370)

Other income (expense)                          3           (36)          883              4

Interest expense                             (112)          (84)         (317)          (254)

Earnings (loss) before income taxes          (742)       (1,113)          931           (620)

Income tax expense (benefit)                 (268)         (382)          326           (227)

Earnings (loss) before
 minority interests                          (474)         (731)          605           (393)

Minority interests                             81            11           158             48

Net earnings (loss)                    $     (555)   $     (742)   $      447*    $     (441)

Net earnings (loss) per share
           Basic                       $    (0.22)   $    (0.30)   $     0.18     $    (0.18)
           Diluted                     $    (0.22)   $    (0.30)   $     0.18     $    (0.18)
Weighted average number of common
 shares outstanding (in thousands)
           Basic                            2,492         2,492         2,492          2,491
           Diluted                          2,494         2,493         2,493          2,495
</TABLE>

* Includes a non-recurring after-tax gain on the sale of property in the amount
of $540,000, or $.22 per diluted share.

<PAGE>

                      Condensed Consolidated Balance Sheets
                                 (in thousands)

                                      January 31    April 30
                                        2006          2005
                                     -----------   ----------
                                     (unaudited)
Assets
Cash and cash equivalents            $       890   $      225
Restricted cash                              381          379
Receivables, less allowances              19,103       21,683
Inventories                                6,539        3,542
Prepaid expenses and
 other current assets                      1,338          951
   Total current assets                   28,251       26,780
Net property, plant and equipment         11,161       10,730
Other assets                               7,602        8,702
Total Assets                         $    47,014   $   46,212

Liabilities and
 Stockholders' Equity
Short-term borrowings                $     6,244   $    3,778
Current portion of long-term debt             93          931
Current obligations under
 capital leases                              220          111
Accounts payable                           6,873        8,558
Other current liabilities                  3,310        3,021
   Total current liabilities              16,740       16,399
Other non-current liabilities              4,342        3,824
Total stockholders' equity                25,932       25,989
Total Liabilities and
 Stockholders' Equity                $    47,014   $   46,212

      Contact:  D. Michael Parker
                704/871-3290

SOURCE  Kewaunee Scientific Corporation
    -0-                             02/22/2006
    /CONTACT:  D. Michael Parker of Kewaunee Scientific Corporation,
+1-704-871-3290/
    /Web site:  http://www.kewaunee.com /
    (KEQU)
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
